Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeff M Bronstein

Showing results (101-110 of 111) with videos related to

Pageof 12
Sort By:
European Journal of Neurology|December 30, 2022
WITHDRAWN: European Academy of Neurology/Movement Disorder Society European Section's guidelines on pallidotomy for Parkinson's disease: let's remain accurateMarwan Hariz, Anthony E Lang, Jeff M Bronstein, et al.
Molecular Neurodegeneration|December 11, 2025
The pesticide chlorpyrifos increases the risk of Parkinson's diseaseKazi Md Mahmudul Hasan, Lisa M Barnhill, Kimberly C Paul, et al.
Translational Neurodegeneration|March 20, 2023
Toward a biomarker panel measured in CNS-originating extracellular vesicles for improved differential diagnosis of Parkinson's disease and multiple system atrophyHash Brown Taha, Simon Hornung, Suman Dutta, et al.
Molecular Neurodegeneration|August 10, 2018
Joint genome-wide association study of progressive supranuclear palsy identifies novel susceptibility loci and genetic correlation to neurodegenerative diseasesJason A Chen, Zhongbo Chen, Hyejung Won, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 7, 2019
Genome-wide survey of copy number variants finds MAPT duplications in progressive supranuclear palsyZhongbo Chen, Jason A Chen, Aleksey Shatunov, et al.
Archives of Neurology|October 13, 2010
Deep brain stimulation for Parkinson disease: an expert consensus and review of key issuesJeff M Bronstein, Michele Tagliati, Ron L Alterman, et al.
Acta Neuropathologica|May 15, 2021
α-Synuclein in blood exosomes immunoprecipitated using neuronal and oligodendroglial markers distinguishes Parkinson's disease from multiple system atrophySuman Dutta, Simon Hornung, Adira Kruayatidee, et al.
Acta Neuropathologica|May 24, 2021
Correction to: α-Synuclein in blood exosomes immunoprecipitated using neuronal and oligodendroglial markers distinguishes Parkinson's disease from multiple system atrophySuman Dutta, Simon Hornung, Adira Kruayatidee, et al.
The New England Journal of Medicine|June 4, 2010
Pallidal versus subthalamic deep-brain stimulation for Parkinson's diseaseKenneth A Follett, Frances M Weaver, Matthew Stern, et al.
Neurology|June 23, 2012
Randomized trial of deep brain stimulation for Parkinson disease: thirty-six-month outcomesFrances M Weaver, Kenneth A Follett, Matthew Stern, et al.
Pageof 12

Showing results (101-110 of 111) with videos related to

Sort By:
Pageof 12
European Journal of Neurology|December 30, 2022
WITHDRAWN: European Academy of Neurology/Movement Disorder Society European Section's guidelines on pallidotomy for Parkinson's disease: let's remain accurateMarwan Hariz, Anthony E Lang, Jeff M Bronstein, et al.
Molecular Neurodegeneration|December 11, 2025
The pesticide chlorpyrifos increases the risk of Parkinson's diseaseKazi Md Mahmudul Hasan, Lisa M Barnhill, Kimberly C Paul, et al.
Translational Neurodegeneration|March 20, 2023
Toward a biomarker panel measured in CNS-originating extracellular vesicles for improved differential diagnosis of Parkinson's disease and multiple system atrophyHash Brown Taha, Simon Hornung, Suman Dutta, et al.
Molecular Neurodegeneration|August 10, 2018
Joint genome-wide association study of progressive supranuclear palsy identifies novel susceptibility loci and genetic correlation to neurodegenerative diseasesJason A Chen, Zhongbo Chen, Hyejung Won, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 7, 2019
Genome-wide survey of copy number variants finds MAPT duplications in progressive supranuclear palsyZhongbo Chen, Jason A Chen, Aleksey Shatunov, et al.
Archives of Neurology|October 13, 2010
Deep brain stimulation for Parkinson disease: an expert consensus and review of key issuesJeff M Bronstein, Michele Tagliati, Ron L Alterman, et al.
Acta Neuropathologica|May 15, 2021
α-Synuclein in blood exosomes immunoprecipitated using neuronal and oligodendroglial markers distinguishes Parkinson's disease from multiple system atrophySuman Dutta, Simon Hornung, Adira Kruayatidee, et al.
Acta Neuropathologica|May 24, 2021
Correction to: α-Synuclein in blood exosomes immunoprecipitated using neuronal and oligodendroglial markers distinguishes Parkinson's disease from multiple system atrophySuman Dutta, Simon Hornung, Adira Kruayatidee, et al.
The New England Journal of Medicine|June 4, 2010
Pallidal versus subthalamic deep-brain stimulation for Parkinson's diseaseKenneth A Follett, Frances M Weaver, Matthew Stern, et al.
Neurology|June 23, 2012
Randomized trial of deep brain stimulation for Parkinson disease: thirty-six-month outcomesFrances M Weaver, Kenneth A Follett, Matthew Stern, et al.
Pageof 12